Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated other comprehensive loss	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 198,942	$ 52	$ 612,025	$ (797)	$ (412,338)
Beginning balance, Shares at Dec. 31, 2022		52,099,211
Issuance of common stock, net of issuance costs	117,346	$ 10	117,336
Issuance of common stock, Shares		9,615,384
Issuance of common stock under employee benefit plans	777		777
Issuance of common stock under employee benefit plans, Shares		182,628
Vesting of restricted stock awards, Shares		18,144
Stock-based compensation expense	14,802		14,802
Unrealized gain on marketable securities	661			661
Net Income (Loss)	(97,335)				(97,335)
Ending balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Ending balance, Shares at Dec. 31, 2023		61,915,367
Issuance of common stock under employee benefit plans	2,746		2,746
Issuance of common stock under employee benefit plans, Shares		530,610
Vesting of restricted stock awards, Shares		22,326
Issuance of pre-funded warrants in exchange for common stock, value		$ (9)	9
Issuance of pre-funded warrants in exchange for common stock, Shares		(9,350,000)
Issuance of common stock pursuant to pre-funded warrant exercise		$ 1	(1)
Issuance of common stock pursuant to pre-funded warrant exercise shares		850,000
Stock-based compensation expense	14,554		14,554
Unrealized gain on marketable securities	266			266
Net Income (Loss)	(9,725)				(9,725)
Ending balance at Dec. 31, 2024	$ 243,034	$ 54	$ 762,248	$ 130	$ (519,398)
Ending balance, Shares at Dec. 31, 2024		53,968,303